INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

GDRXGoodRx Holdings, Inc.

CIK 0001809519

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 0
Max Insider Score21
Connections10with evidence

GDRX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
HJ
Hirsch Douglas JosephDirector
GDRXGoodRx Holdings, Inc.
Option exercise
M—
20.5K sh
Oct 26, 2026Oct 26, 2026
traded Oct 26, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Telecommunications & technologySEC SIC 7374 · Services-Computer Processing & Data Preparation · Nov 4, 2026
  • ← Insider ofevidence
    Fengler JustinSee Remarks · Aug 12, 2026
  • ← Insider ofevidence
    Bezdek TrevorDirector · Jun 10, 2026
  • ← Insider ofevidence
    Hirsch Douglas JosephDirector · May 29, 2026
9
HJ
Hirsch Douglas JosephDirector
GDRXGoodRx Holdings, Inc.
Option exercise
M
—
20.5K sh
Oct 26, 2026
Oct 26, 2026
traded Oct 26, 2026
+0d
SEC FORM 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
115.1K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

16
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$163K
48.2K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
111.0K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

17
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$48K
14.2K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
115.1K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

12
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$75K
22.2K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

16
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$169K
50.0K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
5,793 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

17
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$9,964
2,948 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
32.5K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

21
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
32.5K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
111.0K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
51.2K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

17
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
5,793 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

9
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
51.2K sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

17
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,335 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$1,175
330 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$3,645
1,024 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,335 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

17
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,101 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$3,806
1,069 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,101 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
752 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
752 sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
6,392 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

17
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
6,423 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$2,380
638 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$3,200
858 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

17
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,636 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$5,006
1,342 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

17
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
4,541 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

17
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
1,686 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
2,636 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
4,541 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

17
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
10.1K sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$17K
4,575 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

17
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
6,423 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$11K
2,817 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$10K
2,803 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

17
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$42K
11.2K sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

9
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
10.1K sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
6,392 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

21
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
25.6K sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

17
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Tax withholding
F$8,620
2,311 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

9
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
1,252 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
1,252 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

21
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
25.6K sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

13
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Option exercise
M—
1,686 sh
Aug 15, 2026Aug 17, 2026
traded Aug 15, 2026
+2dSEC FORM 4

Evidence

9
FJ
Fengler JustinSee Remarks
GDRXGoodRx Holdings, Inc.
Grant or award
A—
190.2K sh
Aug 10, 2026Aug 12, 2026
traded Aug 10, 2026
+2dSEC FORM 4

Evidence

21
BT
Bezdek TrevorDirector
GDRXGoodRx Holdings, Inc.
Grant or award
A—
110.3K sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC FORM 4

Evidence

9
BE
Bruehlman Ronald EDirector
GDRXGoodRx Holdings, Inc.
Grant or award
A—
4,642 sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence

9
HJ
Hirsch Douglas JosephDirector
GDRXGoodRx Holdings, Inc.
Grant or award
A—
4,642 sh
May 27, 2026May 29, 2026
traded May 27, 2026
+2dSEC FORM 4

Evidence

9
CT
Chan Thomas (TC)Chief Accounting Officer
GDRXGoodRx Holdings, Inc.
Grant or award
A—
54.5K sh
May 11, 2026May 12, 2026
traded May 11, 2026
+1dSEC FORM 4

Evidence

13
MA
McGinnis Christopher ASee Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
37.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC FORM 4

Evidence

16
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Tax withholding
F$112K
50.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC FORM 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
111.0K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC FORM 4

Evidence

21
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
51.2K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC FORM 4

Evidence

13
BL
Barnes Wendy LynnDirector, See Remarks
GDRXGoodRx Holdings, Inc.
Option exercise
M—
115.1K sh
Apr 15, 2026Apr 15, 2026
traded Apr 15, 2026
+0dSEC FORM 4

Evidence

← Insider ofevidence
Chan Thomas (TC)
Chief Accounting Officer · May 12, 2026
  • ← Insider ofevidence
    McGinnis Christopher ASee Remarks · Apr 15, 2026
  • ← Insider ofevidence
    Wagner ScottDirector · Jan 21, 2026
  • ← Insider ofevidence
    Barnes Wendy LynnDirector, See Remarks · Jan 15, 2026
  • ← Insider ofevidence
    Bruehlman Ronald EDirector · Nov 10, 2025
  • ← Insider ofevidence
    Nabiey RominChief Accounting Officer · Nov 10, 2025